Stay updated on Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; Back to Top link removed. No substantive changes to core content, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-13T17:33:10.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T14:50:24.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, as well as additional medical terms related to ocular melanoma and various proteins, while some previous terms and locations have been removed.
    Difference
    3%
    Check dated 2025-08-30T11:37:21.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:29:59.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-08T23:48:03.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated to version v2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    1%
    Check dated 2025-08-01T19:15:25.000Z thumbnail image

Stay in the know with updates to Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial page.